Artículos por temáticas

What's next after the exciting discovery and reassuring replications of genome-wide association studies of restless legs syndrome?

Xiong L.

Sleep Med. 2011 Sep;12(8):733-4. doi: 10.1016/j.sleep.2011.08.001. No abstract available.

Restless legs syndrome and periodic leg movements in sleep.

Earley CJ, Allen RP, Hening W.

Handb Clin Neurol. 2011;99:913-48. doi: 10.1016/B978-0-444-52007-4.00015-1. No abstract available.

Treatment of restless legs syndrome with rotigotine.

García-Borreguero D, Oertel W, Trenkwalder C; SP710 study group..

Lancet Neurol. 2011 Oct;10(10):872-3. doi: 10.1016/S1474-4422(11)70218-6. No abstract available.

Cluster headache patients are not affected by restless legs syndrome: an observational study.

Florindo D, Daniela C, Giulio C, Vittorio P, Gabriella M, Vincenzo T, Eliana M, Gerardo C, Gennaro B.

Clin Neurol Neurosurg. 2011 May;113(4):308-10. doi: 10.1016/j.clineuro.2010.12.006.

[Restless legs syndrome: the most prevalent unknown" disorder]."

Lindner A, Novák M, Molnár MZ.

Orv Hetil. 2011 Feb 13;152(7):259-66. doi: 10.1556/OH.2011.29035. Hungarian.

Levodopa for restless legs syndrome.

Scholz H, Trenkwalder C, Kohnen R, Riemann D, Kriston L, Hornyak M.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD005504. doi: 10.1002/14651858.CD005504.pub2. Review.

The restless legs syndrome: is it more than that?

Shneerson JM.

Br J Hosp Med (Lond). 2011 Apr;72(4):219-23. Review. No abstract available.

Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population.

Yang Q, Li L, Chen Q, Foldvary-Schaefer N, Ondo WG, Wang QK.

Sleep Med. 2011 Sep;12(8):800-4. doi: 10.1016/j.sleep.2011.06.006.

A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome.

Silver N, Allen RP, Senerth J, Earley CJ.

Sleep Med. 2011 May;12(5):440-4. doi: 10.1016/j.sleep.2010.11.002.

Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome.

Voon V, Schoerling A, Wenzel S, Ekanayake V, Reiff J, Trenkwalder C, Sixel-Döring F.

BMC Neurol. 2011 Sep 28;11:117. doi: 10.1186/1471-2377-11-117.

Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study.

Misra UK, Kalita J, Kumar B, Prasad S.

Neurology. 2011 Jan 25;76(4):408; author reply 408-9. doi: 10.1212/WNL.0b013e3181fe7217. No abstract available.

Incidence of restless legs syndrome in two population-based cohort studies in Germany.

Szentkiralyi A, Fendrich K, Hoffmann W, Happe S, Berger K.

Sleep Med. 2011 Oct;12(9):815-20. doi: 10.1016/j.sleep.2011.06.016.

Iron status and chronic kidney disease predict restless legs syndrome in an older hospital population.

Quinn C, Uzbeck M, Saleem I, Cotter P, Ali J, O'Malley G, Gilmartin JJ, O'Keeffe ST.

Sleep Med. 2011 Mar;12(3):295-301. doi: 10.1016/j.sleep.2010.08.014.

The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.

Luo F, Li C, Ondo WG, Xu P, Xie W, Le W.

Sleep Med. 2011 Jan;12(1):41-6. doi: 10.1016/j.sleep.2010.07.009.

[Restlessness instead of sleep. Restless legs syndrome].

Rémi J.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Dec;54(12):1332-6. doi: 10.1007/s00103-011-1369-z. German.